Biocon Limited

NSEI:BIOCON Stock Report

Market Cap: ₹485.3b

Biocon Management

Management criteria checks 3/4

Biocon's CEO is Siddharth Mittal, appointed in Dec 2019, has a tenure of 5.75 years. total yearly compensation is ₹73.71M, comprised of 97.2% salary and 2.8% bonuses, including company stock and options. directly owns 0.062% of the company’s shares, worth ₹302.12M. The average tenure of the management team and the board of directors is 2.8 years and 3.8 years respectively.

Key information

Siddharth Mittal

Chief executive officer

₹73.7m

Total compensation

CEO salary percentage97.19%
CEO tenure5.8yrs
CEO ownership0.06%
Management average tenure2.8yrs
Board average tenure3.8yrs

Recent management updates

Recent updates

Biocon Limited Just Missed Earnings - But Analysts Have Updated Their Models

Aug 10
Biocon Limited Just Missed Earnings - But Analysts Have Updated Their Models

Pinning Down Biocon Limited's (NSE:BIOCON) P/E Is Difficult Right Now

Aug 04
Pinning Down Biocon Limited's (NSE:BIOCON) P/E Is Difficult Right Now

Biocon Limited Just Recorded A 16% EPS Beat: Here's What Analysts Are Forecasting Next

Jun 19
Biocon Limited Just Recorded A 16% EPS Beat: Here's What Analysts Are Forecasting Next

Biocon (NSE:BIOCON) Will Pay A Dividend Of ₹0.50

Jun 18
Biocon (NSE:BIOCON) Will Pay A Dividend Of ₹0.50

Biocon (NSE:BIOCON) Has Affirmed Its Dividend Of ₹0.50

May 12
Biocon (NSE:BIOCON) Has Affirmed Its Dividend Of ₹0.50

Estimating The Intrinsic Value Of Biocon Limited (NSE:BIOCON)

Apr 18
Estimating The Intrinsic Value Of Biocon Limited (NSE:BIOCON)

Biocon Limited's (NSE:BIOCON) Business Is Trailing The Market But Its Shares Aren't

Mar 10
Biocon Limited's (NSE:BIOCON) Business Is Trailing The Market But Its Shares Aren't

Does Biocon (NSE:BIOCON) Have A Healthy Balance Sheet?

Feb 20
Does Biocon (NSE:BIOCON) Have A Healthy Balance Sheet?

Biocon Limited Just Missed EPS By 81%: Here's What Analysts Think Will Happen Next

Feb 02
Biocon Limited Just Missed EPS By 81%: Here's What Analysts Think Will Happen Next

Is Now The Time To Put Biocon (NSE:BIOCON) On Your Watchlist?

Jan 19
Is Now The Time To Put Biocon (NSE:BIOCON) On Your Watchlist?

A Look At The Intrinsic Value Of Biocon Limited (NSE:BIOCON)

Jan 03
A Look At The Intrinsic Value Of Biocon Limited (NSE:BIOCON)
User avatar

Tactical Biosimilars Expansion And Viatris Integration Will Propel Revenue Growth And Boost Profitability

Strategic cost improvements and production efficiencies are set to enhance margins and profitability in the generics segment.

Here's What Analysts Are Forecasting For Biocon Limited (NSE:BIOCON) After Its Second-Quarter Results

Nov 02
Here's What Analysts Are Forecasting For Biocon Limited (NSE:BIOCON) After Its Second-Quarter Results

Why Investors Shouldn't Be Surprised By Biocon Limited's (NSE:BIOCON) Low P/E

Nov 01
Why Investors Shouldn't Be Surprised By Biocon Limited's (NSE:BIOCON) Low P/E

Do Biocon's (NSE:BIOCON) Earnings Warrant Your Attention?

Oct 14
Do Biocon's (NSE:BIOCON) Earnings Warrant Your Attention?

These 4 Measures Indicate That Biocon (NSE:BIOCON) Is Using Debt Extensively

Sep 20
These 4 Measures Indicate That Biocon (NSE:BIOCON) Is Using Debt Extensively

CEO Compensation Analysis

How has Siddharth Mittal's remuneration changed compared to Biocon's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2025n/an/a

₹4b

Mar 31 2025₹74m₹72m

₹10b

Dec 31 2024n/an/a

₹8b

Sep 30 2024n/an/a

₹14b

Jun 30 2024n/an/a

₹16b

Mar 31 2024₹57m₹57m

₹10b

Dec 31 2023n/an/a

₹12b

Sep 30 2023n/an/a

₹5b

Jun 30 2023n/an/a

₹4b

Mar 31 2023₹48m₹48m

₹5b

Dec 31 2022n/an/a

₹4b

Sep 30 2022n/an/a

₹6b

Jun 30 2022n/an/a

₹7b

Mar 31 2022₹42m₹42m

₹6b

Dec 31 2021n/an/a

₹7b

Sep 30 2021n/an/a

₹7b

Jun 30 2021n/an/a

₹7b

Mar 31 2021₹43m₹43m

₹7b

Dec 31 2020n/an/a

₹6b

Sep 30 2020n/an/a

₹6b

Jun 30 2020n/an/a

₹7b

Mar 31 2020₹49m₹31m

₹8b

Compensation vs Market: Siddharth's total compensation ($USD836.17K) is about average for companies of similar size in the Indian market ($USD791.19K).

Compensation vs Earnings: Siddharth's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.

CEO

Siddharth Mittal (47 yo)

5.8yrs
Tenure
₹73,710,000
Compensation

Mr. Siddharth Mittal, BCom, CA, CPA has been CEO and Director of Biocon Limited since December 1, 2019. He has been Managing Director of Biocon Limited since April 01, 2020 and served as its Joint Managing...

Leadership Team

NamePositionTenureCompensationOwnership
Kiran Mazumdar-Shaw
Founder & Executive Chairperson46.8yrs₹42.28m36.31%
₹ 176.2b
Siddharth Mittal
MD, CEO & Director5.8yrs₹73.71m0.062%
₹ 302.1m
Mukesh Kamath K
Interim CFO & Nodal Officer1.3yrsno datano data
Arun Gupta
Chief Operating Officer2.4yrsno datano data
Saurabh Paliwal
Head of Investor Relations3.1yrsno datano data
Ekta Agarwal
Interim Company Secretary & Compliance Officerless than a yearno datano data
Seema Ahuja
SVP & Global Head Corporate Communications & Corporate Brand Biocon Groupno datano datano data
Maninder Puri
Head of Human Resourcesno datano datano data
Paul Thomas
Chief Commercial Officerno datano datano data
Abhijit Zutshi
Chief Commercial Officerno datano data0.017%
₹ 80.8m
Manoj Pananchukunnath
Chief Scientific Officerno datano data0.0066%
₹ 32.0m
Matthew Erick
Chief Commercial Officer of Advanced Markets - Biocon Biologics3.7yrsno datano data
2.8yrs
Average Tenure
52yo
Average Age

Experienced Management: BIOCON's management team is considered experienced (2.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Kiran Mazumdar-Shaw
Founder & Executive Chairperson46.8yrs₹42.28m36.31%
₹ 176.2b
Siddharth Mittal
MD, CEO & Director5.8yrs₹73.71m0.062%
₹ 302.1m
Ravi Mazumdar
Non-Executive Non-Independent Director25.1yrs₹6.80m0.40%
₹ 1.9b
Bobby Parikh
Independent Non-Executive Director7.2yrs₹8.33mno data
Naina Lal Kidwai
Lead Independent Director3.4yrs₹6.80mno data
Satish Garg
Member of Scientific Advisory Boardno datano datano data
Nicholas Haggar
Independent Director1.8yrs₹7.56mno data
Shashank Joshi
Member of Scientific Advisory Boardno datano datano data
Rekha Menon
Independent Director2.2yrs₹6.63mno data
Eric Mazumdar
Non-Executive Director3.8yrs₹5.95m0.24%
₹ 1.2b
John Petrie
Member of Scientific Advisory Boardno datano datano data
Atul Dhawan
Non-Executive and Independent Director1.3yrs₹6.63mno data
3.8yrs
Average Tenure
63.5yo
Average Age

Experienced Board: BIOCON's board of directors are considered experienced (3.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/09/06 16:20
End of Day Share Price 2025/09/05 00:00
Earnings2025/06/30
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Biocon Limited is covered by 48 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Meeta ShettyAsian Markets Securities Private Limited
Harith AhamedAvendus Spark
Vijayaraghavan SwaminathanAvendus Spark